Mineralys Therapeutics, Inc.

Historical 13F Holders

Symbol
MLYS
CUSIP
603170101
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 603170101 since 12/18/2024, largest first.

Filer % of Class Filed
Catalys Pacific Fund, LP 13G/A
10.1% 2/13/2026
Event 12/31/2025
RA Capital Management, L.P. 13D/A
9.9% 9/8/2025
Event 9/4/2025
Samsara BioCapital, L.P. 13D/A
8.2% 9/8/2025
Event 9/4/2025
BlackRock, Inc. 13G 5.2% 1/21/2026
Event 12/31/2025
FMR LLC 13G/A
5.1% 8/6/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Andera Partners 13G/A
4.2% 8/14/2025
Event 6/30/2025
Adams Street Partners, LLC 13G/A
2.3% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 220 97.0 M $2.42B
2026 Q2 227 99.7 M $2.69B
2026 Q1 218 90.3 M $2.46B
2025 Q4 228 88.4 M $3.21B
2025 Q3 195 79.3 M $3.01B
2025 Q2 169 65.7 M $889M
2025 Q1 157 61.2 M $971M
2024 Q4 111 46.5 M $572M
2024 Q3 107 44.4 M $540M
2024 Q2 95 44.2 M $517M
2024 Q1 93 41.9 M $540M
2023 Q4 88 34.7 M $299M
2023 Q3 78 26.5 M $252M
2023 Q2 69 25.2 M $429M
2023 Q1 67 24.6 M $385M